Alexandru Rusu

Class off: 

2015

Motivation:

To cross the border line between social and health sciences and bridge the gap. Gain analytical sophistication while answering a public policy-relevant research question.

Education and experience:

Alexandru Rusu is a professional PhD candidate with the Utrecht Centre for Pharmaceutical Policy and Regulation. He has 10 years of progressive experience in healthcare and governance in emerging markets. He is also policy advisor in the Global Policy team at Pfizer. He joined Pfizer in 2011 after having worked for various healthcare stakeholders in Romania and in Belgium.

Alexandru holds a Bachelor’s degree in Political Science from the National School of Political Science and Public Administration in Bucharest as well as a MPP degree from the Hertie School of Governance in Berlin. He also holds a certificate in European Law and a Master’s degree in European Integration.

Title PhD project:

How countries learn?

PhD project description:

My research looks at theories of policy transfer and tries to apply this approach to pharmaceutical public policies. Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. I focus on the transfer of pharmaceutical polices. We generally understand this process as government driven, but actually there is a big role for non-government actors (consultants, private sector, industry association, non-governmental organizations, policy entrepreneurs etc.). I go beyond the traditional state to state transfer analysis and look at the role of unconventional actors and their techniques of transfer (trainings, exchanges, study-tours, conferences, etc.).

Team members and other people involved:

Dr. Anke Hövels, Alin Preda (University of Medicine and Pharmacy „Carol Davila”, Bucharest), Prof. Dr. Bert Leufkens

Publications:

Alexandru Rusu, Katja Kuokkanen, Annabelle Heier. Current trends in the Pharmaceutical Industry – A case study approach. European Journal of Pharmaceutical Sciences, 44 (2011) 437–440